Elevated risk of invasive group a streptococcal disease and host genetic variation in the human leukocyte antigen locus
File(s)s41435-019-0082-z.pdf (848.66 KB)
Published version
Author(s)
Type
Journal Article
Abstract
Invasive group A streptococcal (GAS) disease is uncommon but carries a high casefatality rate relative to other infectious diseases. Given the ubiquity of mild GAS
infections, it remains unclear why healthy individuals will occasionally develop lifethreatening infections, raising the possibility of host genetic predisposition. Here, we
present the results of a case-control study including 43 invasive GAS cases and
1,540 controls. Using HLA imputation and linear mixed-models, we find each copy of
the HLA-DQA1*01:03 allele associates with a two-fold increased risk of disease
(odds ratio 2.3, 95% confidence interval 1.3-4.4, P=0.009), an association which
persists with classical HLA typing of a subset of cases and analysis with an
alternative large control dataset with validated HLA data. Moreover, we propose the
association is driven by the allele itself rather than the background haplotype. Overall
this finding provides impetus for further investigation of the immunogenetic basis of
this devastating bacterial disease.
infections, it remains unclear why healthy individuals will occasionally develop lifethreatening infections, raising the possibility of host genetic predisposition. Here, we
present the results of a case-control study including 43 invasive GAS cases and
1,540 controls. Using HLA imputation and linear mixed-models, we find each copy of
the HLA-DQA1*01:03 allele associates with a two-fold increased risk of disease
(odds ratio 2.3, 95% confidence interval 1.3-4.4, P=0.009), an association which
persists with classical HLA typing of a subset of cases and analysis with an
alternative large control dataset with validated HLA data. Moreover, we propose the
association is driven by the allele itself rather than the background haplotype. Overall
this finding provides impetus for further investigation of the immunogenetic basis of
this devastating bacterial disease.
Date Issued
2020-01
Date Acceptance
2019-06-11
Citation
Genes and Immunity, 2020, 21, pp.63-70
ISSN
1466-4879
Publisher
Springer Nature
Start Page
63
End Page
70
Journal / Book Title
Genes and Immunity
Volume
21
Copyright Statement
© The Author(s) 2019. This article is published with open access. This article is licensed under a Creative Commons
Attribution 4.0 International License, which permits use, sharing,
adaptation, distribution and reproduction in any medium or format, as
long as you give appropriate credit to the original author(s) and the
source, provide a link to the Creative Commons license, and indicate if
changes were made. The images or other third party material in this
article are included in the article’s Creative Commons license, unless
indicated otherwise in a credit line to the material. If material is not
included in the article’s Creative Commons license and your intended
use is not permitted by statutory regulation or exceeds the permitted
use, you will need to obtain permission directly from the copyright
holder. To view a copy of this license, visit http://creativecommons.
org/licenses/by/4.0/.
Attribution 4.0 International License, which permits use, sharing,
adaptation, distribution and reproduction in any medium or format, as
long as you give appropriate credit to the original author(s) and the
source, provide a link to the Creative Commons license, and indicate if
changes were made. The images or other third party material in this
article are included in the article’s Creative Commons license, unless
indicated otherwise in a credit line to the material. If material is not
included in the article’s Creative Commons license and your intended
use is not permitted by statutory regulation or exceeds the permitted
use, you will need to obtain permission directly from the copyright
holder. To view a copy of this license, visit http://creativecommons.
org/licenses/by/4.0/.
Sponsor
National Institute for Health Research
National Institute for Health Research
GlaxoSmithKline Services Unlimited
Imperial College Healthcare NHS Trust- BRC Funding
Identifier
https://www.nature.com/articles/s41435-019-0082-z
Grant Number
HPRU-2012-10047
HPRU-2012-10047
PN1028 GS
RDA02 79560
Subjects
Science & Technology
Life Sciences & Biomedicine
Genetics & Heredity
Immunology
CLASS-II MOLECULES
PYROGENIC EXOTOXIN
STRUCTURAL BASIS
QUALITY-CONTROL
SUSCEPTIBILITY
ASSOCIATION
POLYMORPHISMS
INFECTIONS
IMPUTATION
VARIANTS
1107 Immunology
Immunology
Publication Status
Published
Date Publish Online
2019-08-29